These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37732720)

  • 1. Postchemoradiation magnetic resonance imaging circumferential resection margin predicts treatment failure after multidisciplinary directed sphincter preservation in low rectal cancer.
    Kim SJ; Lee YJ; Park MY; Yang SY; Han YD; Cho MS; Hur H; Lee KY; Lim JS; Min BS
    J Surg Oncol; 2023 Dec; 128(8):1365-1371. PubMed ID: 37732720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
    [No Abstract]   [Full Text] [Related]  

  • 4. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
    Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
    Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI predicts increased eligibility for sphincter preservation after CRT in low rectal cancer.
    Krdzalic J; Beets-Tan RGH; Engelen SME; van Griethuysen J; Lahaye MJ; Lambregts DMJ; Bakers FCH; Vliegen RFA; Beets GL; Maas M
    Radiother Oncol; 2020 Apr; 145():223-228. PubMed ID: 32065902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients?
    Park IJ; Yu CS; Lim SB; Lee JL; Kim CW; Yoon YS; Park SH; Kim JC
    Medicine (Baltimore); 2016 May; 95(18):e3463. PubMed ID: 27149445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes after radical surgery following preoperative chemoradiotherapy for locally advanced lower rectal cancer: abdominoperineal resection versus sphincter-preserving procedure.
    Kim JS; Hur H; Kim NK; Kim YW; Cho SY; Kim JY; Min BS; Ahn JB; Keum KC; Kim H; Sohn SK; Cho CH
    Ann Surg Oncol; 2009 May; 16(5):1266-73. PubMed ID: 19224287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
    Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
    Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
    Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
    JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
    Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
    Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.
    Lin SC; Chen PC; Lee CT; Tsai HM; Lin PC; Chen HH; Wu YH; Lin BW; Su WP; Lee JC
    World J Gastroenterol; 2013 Mar; 19(11):1797-804. PubMed ID: 23555168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of tumor volume reduction in rectal cancer following preoperative chemoradiation.
    Han YB; Oh SN; Choi MH; Lee SH; Jang HS; Lee MA; Kim JG
    Diagn Interv Imaging; 2016 Sep; 97(9):843-50. PubMed ID: 27316573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia.
    Kim KH; Park MJ; Lim JS; Kim NK; Min BS; Ahn JB; Kim TI; Kim HG; Koom WS
    Jpn J Clin Oncol; 2016 Apr; 46(4):316-22. PubMed ID: 26802164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
    São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
    Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
    Wang X; Chen G; Zhang Y; Ghareeb WM; Yu Q; Zhu H; Lu X; Huang Y; Huang S; Hou D; Chi P
    Eur J Surg Oncol; 2020 Jun; 46(6):1118-1123. PubMed ID: 32113887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy.
    Sakuyama N; Kojima M; Kawano S; Matsuda Y; Mino-Kenudson M; Ochiai A; Ito M
    Cancer Sci; 2018 Mar; 109(3):871-878. PubMed ID: 29388280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount Pathology.
    Yuval JB; Thompson HM; Firat C; Verheij FS; Widmar M; Wei IH; Pappou E; Smith JJ; Weiser MR; Paty PB; Nash GM; Shia J; Gollub MJ; Garcia-Aguilar J
    Dis Colon Rectum; 2022 Apr; 65(4):489-496. PubMed ID: 34803147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.